Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00831428
Other study ID # CLE004
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 2009
Est. completion date June 2009

Study information

Verified date April 2019
Source University of Dundee
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Scottish National and District swimming teams will be screened for asthma and rhinitis using both mannitol challenge and sport-based exercise challenge.


Recruitment information / eligibility

Status Completed
Enrollment 97
Est. completion date June 2009
Est. primary completion date May 2009
Accepts healthy volunteers No
Gender All
Age group 11 Years to 23 Years
Eligibility Inclusion Criteria:

- member of the Scottish national and district swimming team

- informed consent obtained

Exclusion Criteria:

- pregnant, lactating or planning to become pregnant

- concomitant use of medicines (prescribed, over-the-counter or herbal) that may interfere with the trial.

- any clinically significant medical condition, as deemed by the clinical investigators, which may endanger the health of the participant or jeopardise the protocol.

- inability to comply with the protocol.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
this is a screening study, not an interventional study

Locations

Country Name City State
United Kingdom The national swimming academy in Stirling Stirling Stirlingshire

Sponsors (1)

Lead Sponsor Collaborator
Brian J Lipworth

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Clearie KL, Williamson PA, Vaidyanathan S, Short P, Goudie A, Burns P, Hopkinson P, Meldrum K, Howaniec L, Lipworth BJ. Disconnect between standardized field-based testing and mannitol challenge in Scottish elite swimmers. Clin Exp Allergy. 2010 May;40(5) — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Tidal Nitric Oxide This test will be performed prior to entering the pool, and on exiting the pool
Secondary Mannitol Challenge This test will be performed once on a district and once on a national squad training day
Secondary Sport-based Challenge This test will be performed once on a district and once on a national squad training day
Secondary Nasal Nitric Oxide This test will be performed prior to entering the pool, and on exiting the pool
Secondary Skin Prick Test This test will be performed once on a district and once on a national squad training day
Secondary Mini Nasal Lavage This test will be performed prior to entering the pool, and on exiting the pool
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device